Speaker illustration

Doctor Sagarika Raman

The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

The role of Ranolazine alone or in combination with a Class III anti-arrhythmic drug for DC cardioversion for persistent AF

Event: EHRA 2024

Topic: Rhythm Control, Cardioversion

Session: Poster session on atrial fibrillation and supraventricular tachycardia

Thumbnail

ESC 365 is supported by